AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05152810 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Evaluations
Description: Before the first stimulation session, just after the 10th session, at 6 weeks, at 12 weeks and at 24 weeks.~The assessment included the collection of AEs/EIGs, the TAC, the VAS on desire to smoke, the TCQ, the QSU, BDI-II (except at S1), the CO tester, GoNoGo, the PQI and the ISI.
Study NCT05152810 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Evaluations
Description: Before the first stimulation session, just after the 10th session, at 6 weeks, at 12 weeks and at 24 weeks.~The assessment included the collection of AEs/EIGs, the TAC, the VAS on desire to smoke, the TCQ, the QSU, BDI-II (except at S1), the CO tester, GoNoGo, the PQI and the ISI.
Study NCT05932602 — intervention group
Intervention type: DEVICE
Intervention: Aveir DR Leadless Pacemaker System
Description: This study will utilize real-world data from patients implanted with the Aveir DR Leadless Pacemaker System. No device intervention is required in this study.
Study NCT05932602 — intervention group
Intervention type: DEVICE
Intervention: Dual Chamber Transvenous Pacemaker
Description: This study will utilize real-world data from patients implanted with a dual-chamber transvenous pacemaker as a comparator to the Aveir DR LP system study arm. No device intervention is required in this study.
Study NCT04232215 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HeraBEAT™
Description: A wireless Smart Fetal Ultrasound Doppler measuring device designed to be self-administered by the expectant mother throughout the different stages of pregnancy
Study NCT04232215 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Doppler fetal heart rate monitor
Description: A hand-held ultrasound transducer that uses the Doppler Effect to provide an audible simulation of the heart beat and displays the number of beats per minute.
Study NCT05297526 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Culturally adapted children's book
Description: Tribe-specific children's book celebrating tribal culture with an embedded oral health message
Study NCT05297526 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard informational brochure on children's oral health
Description: Informational brochure about children's oral health designed by the NIH for American Indian/Alaska Native parents.
Study NCT04924478 — intervention group
Intervention type: BIOLOGICAL
Intervention: Mepolizumab
Description: Patients will be receiving this treatment as part of their standard clinical care
Study NCT04607876 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Technological Facilitator
Description: See Enhanced Intervention Arm for full description.
Study NCT04607876 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Risk factor assessment in first degree relative subjects and implementation of an education program for the randomized participants and their primary care provider.
Study NCT05650853 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transrectal ultrasound
Description: Examinations for observation of the pre, per and post-ejaculatory phases
Study NCT05650853 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Urethroscopy
Description: Examinations for observation of the pre, per and post-ejaculatory phases
Study NCT04471389 — intervention group
Intervention type: OTHER
Intervention: Incidence and risk factors of hypertension
Description: During the follow-up period, General information(age, sex, BMI, blood pressure, the history of drink and smoke, medical history, etc). Blood biochemistry parameters（Lipid, hsCRP levels, etc）and other laboratory examination parameters(arterial stiffness, IMT, FMD) will be collected.
Study NCT05896189 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Arm 1: Computerized Cognitive Training-Global Stimulation Games
Description: The program will includes 8 non-speeded exercises that include spin-offs of such games as breaking hex, lineup four, battleship, gems swap, double klondike, solitaire, reversi, word search, and sudoku. These games are well matched for time on task, novelty, and progression across levels. These are strategy-based games without adaptive, speeded, or accuracy-based algorithms underlying their personalization.
Study NCT05896189 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Arm 2: Computerized Cognitive Training-Neuroplasticity Games
Description: Cognitive training exercises include Double Decision (targets visual speed of processing and useful field of view), Target Tracker (targets visuospatial working memory capacity), Visual Sweeps (targets speed of processing), Syllable Stacks (targets auditory memory), Eye for Detail (targets eye movement speed and visuo-spatial working memory), Mind Bender (targets mental flexibility), Divided Attention (a shape-color-pattern inhibitory control exercise that focuses on rapidly determining whether flashing colors, shapes, or patterns meet a pre-specified rule), Right Turn (targets spatial reasoning).
Study NCT04997564 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Tenofovir Alafenamide 25 MG
Description: All the patients will use prophylactically TAF for 4 weeks before using SOF/VEL once daily for 12 weeks. Group 1 patients will be discontinued TAF once daily therapy at the end of week 28 if no HBV reactivation occurs during treatment .
Study NCT04997564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenofovir Alafenamide 25 MG
Description: All the patients will use prophylactically TAF for 4 weeks before using SOF/VEL once daily for 12 weeks. Group 1 patients will be discontinued TAF once daily therapy at the end of week 28 if no HBV reactivation occurs during treatment .
Study NCT04997564 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Sofosbuvir / Velpatasvir
Description: All the patients will use prophylactically TAF for 4 weeks before using SOF/VEL once daily for 12 weeks. Group 2 patients will be received TAF once daily for 64 weeks. In this study, after week 64.
Study NCT04997564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sofosbuvir / Velpatasvir
Description: All the patients will use prophylactically TAF for 4 weeks before using SOF/VEL once daily for 12 weeks. Group 2 patients will be received TAF once daily for 64 weeks. In this study, after week 64.
Study NCT05536856 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: a new effervescent mixture 5-florouracil formula
Description: 30 patients will apply a new effervescent mixture 5-florouracil formula prepared at faculty of pharmacy (Girls) - Al-Azhar university
Study NCT05536856 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil plain powder
Description: 30 patients will apply the 5-florouracil plain powder on the selected patch followed by 3 milliliters of water till complete dissolution of the powder
Study NCT06547060 — intervention group
Intervention type: OTHER
Intervention: Exercise leggings
Description: The participants will wear two types of leggings (i.e., control leggings vs. leggings with shortened resistance bands) while performing the same exercise on two different days, respectively.
Study NCT05017818 — intervention group
Intervention type: OTHER
Intervention: Observational retrospective data
Description: Non-intervention
Study NCT05334277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furmonertinib
Description: Furmonertinib 80mg QD
Study NCT05334277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furmonertinib/Pemetrexed/Carboplatin
Description: Furmonertinib 80mg daily + Pemetrexed (500 mg/m2) plus carboplatin (AUC 5) on Day 1 of 21day cycles (every 3 weeks) for 4 cycles, followed by pemetrexed maintenance (500 mg/m2) every 3 weeks.
Study NCT05334277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furmonertinib/Pemetrexed/Carboplatin/Bevacizumab
Description: Furmonertinib 80mg daily + Pemetrexed (500 mg/m2) plus carboplatin (AUC 5) plus bevacizumab (7.5mg/kg) on Day 1 of 21day cycles (every 3 weeks) for 4 cycles, followed by pemetrexed (500 mg/m2) with bevacizumab (7.5mg/kg) maintenance every 3 weeks.
Study NCT06219421 — intervention group
Intervention type: OTHER
Intervention: Clinical data reuse
Description: Clinical data reuse
Study NCT06337591 — intervention group
Intervention type: PROCEDURE
Intervention: VI-RADS
Description: Patients with suspected bladder cancer underwent multiparametric magnetic resonance imaging (mMRI) and vescical imaging reporting and data system (VI-RADS) score calculation. After trans-urethral resection of bladder (TURB), the results of biopsy were compared to the VI-RADS score to verify their concordance.
Study NCT05330793 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Oral probiotic
Description: an oral probiotic intervention with or without a novel ADP1 toothpaste
Study NCT05330793 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Oral probiotic
Description: an oral probiotic intervention with or without a novel ADP1 toothpaste
Study NCT05330793 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Placebo
Description: placebo without Oral probiotic or toothpaste
Study NCT05330793 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo without Oral probiotic or toothpaste
Study NCT04868279 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web-Based Interactive Nurse Support Program Based on Health Promotion Model
Description: Nursing education will be given on healthy behaviors such as nutrition, exercise, health responsibility and stress management according to the health promotion model. The researcher will make phone calls with the intervention group for 6 months (12 times in total), twice a month. During telephone interviews, individuals will be talking about the use of the website, the points that are not understood or need to be emphasized, their application of health promotion behaviors, the obstacles they experience during the application and the suggestions for this.
Study NCT04816695 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VOC analysis
Description: VOC analysis in exhaled air with e-noses and mass spectrometry.
Study NCT06593691 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional treatment
Description: Hot Pack, TENS, therapeutic ultrasound, and exercise
Study NCT06593691 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional treatment
Description: Hot Pack, TENS, therapeutic ultrasound, and exercise
Study NCT06593691 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional treatment + multi-wave locked system laser treatment
Description: Hot Pack, TENS, therapeutic ultrasound, and exercise + multi-wave locked system laser treatment
Study NCT06168045 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cerebral tissue oxygenation and blood pressure measurement
Description: Measurement of cerebral tissue oxygenation with NIRS and blood pressure during immediate transition after birth
Study NCT06554509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1819 injection
Description: SHR-1819 injection
Study NCT06554509 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo
Study NCT05755178 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music, feelings and relationships - music group for children at shelters
Description: A music group intervention, offered to children 3-10 years who live or have lived at a shelter.~6 group sessions with musicians and music therapist and a group of 4-8 children.~Focus on improving recognition and regulation of emotions, and on relational capacity with adults and peers.
Study NCT05518188 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MELPIDA
Description: MELPIDA, a recombinant serotype 9 adeno-associated virus (AAV) encoding a codon-optimized human AP4M1 transgene
Study NCT05853640 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Usual care at the orthopedic department consists of a clinical examination, radiological imaging, and a diagnostic injection. A recommendation to get physical therapy treatment in primary care will be provided, but this intervention will not be controlled by the investigators in any capacity.
Study NCT04167111 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Cholecalciferol
Description: Vitamin D
Study NCT04974749 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: REPLAGAL
Description: REPLAGAL IV infusion.
Study NCT05065710 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZL-1211
Description: Phase 1 dose escalation part will enroll about 12-42 patients, Phase 2 dose expansion part will enroll about 15-40 patients in each cohort
Study NCT06581367 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tailoring the course duration to the patient's needs.
Description: Patients will be advised to visit the center as soon as they feel better and are afebrile for a clinical assessment including vital signs (temperature, blood pressure, respiratory rate, pulse, and oxygen saturation) and C-reactive protein rapid testing after completing two full days of antibiotic.
Study NCT06581367 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Complete a 7-day course
Description: The antibiotic course must be completed (7 days at least).
Study NCT06260969 — intervention group
Intervention type: DEVICE
Intervention: balloon dilatation
Description: Direct balloon dilation vs stenting vs embolectomy + tirofiban vs embolectomy + balloon dilation vs embolectomy + balloon dilation + intracranial stenting
Study NCT05332418 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: selected exercise program
Description: therapeutic ultrasound, Static neck exercise, Educational postural correction, and Home neck exercise program for patient
Study NCT05332418 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electromagenetic Field therapy
Description: Magnetotherapy application the device will be adjusted around the neck and shoulder area at low frequency (50 Hz), with intensity of 2.5 MT, field shape and applicator type rectangular csl60/csp60) , and the application time (10 minutes)
Study NCT06437912 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Botulinum toxin type A
Description: Eligible patients were randomly assigned to the experimental group and the control group. Patients in the experimental group will be randomized to receive injections of 1 U,2.5 U, and 5 U botulinum toxin type A,Patients in the control group received an injection of 0.9% Nacl
Study NCT06437912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A
Description: Eligible patients were randomly assigned to the experimental group and the control group. Patients in the experimental group will be randomized to receive injections of 1 U,2.5 U, and 5 U botulinum toxin type A,Patients in the control group received an injection of 0.9% Nacl
Study NCT04721340 — intervention group
Intervention type: OTHER
Intervention: Test Group
Description: Individuals who meet the inclusion criteria will be evaluated for manual dexterity, performance, muscle strength and fatigue, respectively, on a predetermined day.
Study NCT04721340 — intervention group
Intervention type: OTHER
Intervention: Control Grup
Description: Individuals who meet the inclusion criteria will be evaluated for manual dexterity, performance, muscle strength and fatigue, respectively, on a predetermined day.
Study NCT06030284 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BurstDR-SCS
Description: Spinal Cord Stimulation with a BurstDR-SCS system.
Study NCT06030284 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BurstDR-SCS
Description: BurstDR-SCS system turned off.
Study NCT04667416 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PalinGen Flow Amniotic Tissue Allograft
Description: Participants will receive wound size-dependent dose of PalinGen Flow liquid human amniotic tissue allograft by subcutaneous injection in addition to SOC.
Study NCT06582966 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Doxycyclin
Description: Open label, single-arm, pilot study of 60 cisgender women taking HIV PrEP in Kisumu, Kenya will be given doxycycline 200 mg orally once weekly with clinical follow-up including quarterly STI testing and treatment for six months.
Study NCT05298800 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Vaccine
Description: Different arms were administrated different vaccines
Study NCT05294458 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cotadutide solution for injection
Description: cotadutide solution for injection
Study NCT04836988 — intervention group
Intervention type: OTHER
Intervention: Three months of digitally delivered osteoarthritis treatment
Description: Digitally delivered osteoarthritis management including education and exercise and weight control if needed
Study NCT05853640 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HIPSTER
Description: Patients will be provided with usual care at the orthopedic department, which consists of a clinical examination, radiological imaging, and a diagnostic injection.~In addition, participants in this group will be referred to physical therapists trained in administering a semi-structured, individualized, progressive treatment. This 16-week intervention targets known physical and psychological impairments in people with long-standing hip and groin pain, using exercise therapy and patient education.
Study NCT04836988 — intervention group
Intervention type: OTHER
Intervention: Three months of face-to-face delivered osteoarthritis treatment
Description: Face-toface delivered osteoarthritis management including education and exercise and weight control if needed
Study NCT06198946 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: External diaphragm pacing（EDP）
Description: After the skin is disinfected, place the small electrode pads on the lower 1/3 of the outer edges of the sternocleidomastoid muscles on the left and right sides, and place the large electrodes on the surface of the pectoralis major muscles on both sides, and fix them with medical tape. Adjust the pacing according to the patient's tolerance. Frequency and stimulation intensity, each treatment time is 20 minutes, treatment is once a day, 5 days a week, and the treatment course is 4 weeks.
Study NCT06198946 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Routine rehabilitation treatment
Description: Participants received comprehensive rehabilitation treatments such as muscle strength training, hemiplegic limb comprehensive training, balance function training, limb neuromuscular electrical stimulation, acupuncture and other comprehensive rehabilitation treatments. Each project was 30 minutes/time, once a day, 5 days a week, and the treatment course was 4 weeks.comprehensive rehabilitation treatments, each item is 30 minutes/time, once a day, 5 days a week, and the treatment course is 4 weeks.
Study NCT06421363 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inclisiran
Description: Implementation of a follow-up program that incorporates Inclisiran treatment in patients with a history of chronic coronary syndrome
Study NCT05081128 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: programmable CSF shunt valve
Description: Brain shunt surgery using a programmable CSF shunt valve
Study NCT05081128 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: programmable CSF shunt valve
Description: Brain shunt surgery using a programmable CSF shunt valve
Study NCT05273294 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Portable color Doppler ultrasound system
Description: In the ultrasound group, the catheter type was selected according to the results of ultrasonic measurement of transverse diameter of cricoid cartilage after induction of general anesthesia, and tracheal intubation was performed with ordinary laryngoscope after measurement
Study NCT05046691 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 8-week mindfulness program
Description: The .b Foundations course is an 8-week mindfulness program developed by Mindfulness in Schools Project (MiSP) for school teachers and personnel. It includes a taster session and 8 weekly sessions. Each session lasts for 1.5 hours with a specific theme (e.g. Lesson 1 waking up from autopilot). Formal and informal mindfulness practices (e.g. mindful eating, body scan, mindful walking, habit releaser etc.), psychoeducation, cognitive exercises, inquiry, and home practice are involved.
Study NCT05203159 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ocean sound
Description: The experimental group will listen to ocean sound, starting at the 1st minute before the ROP examination and ending at the 5th minute after the ROP examination.
Study NCT05203159 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine
Description: No sound will be played before, during and after the ROP examination.
Study NCT05321368 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LINKED-HEARTS Program
Description: The intervention arm will include training on home blood pressure monitoring, Sphygmo blood pressure telemonitoring app, Community Health Worker visit for education, counseling on lifestyles modification and Pharmacist to collaborate with other providers to optimize pharmacologic therapy to improve hypertension outcomes and with payors to ensure consistent access to drug therapy.
Study NCT04633200 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DOT mobile app
Description: DOT is a mobile phone app that has daily pill reminders and supportive texts, as well as various features designed to support PrEP medication adherence.
Study NCT06073587 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Scintigraphy scan
Description: Scans will be performed as specified in the arm description.
Study NCT04150692 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Dara-SC
Description: -Subcutaneous daratumumab and hyaluronidase-fihj
Study NCT04150692 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Dara-SC
Description: -Subcutaneous daratumumab and hyaluronidase-fihj